Prevalence, Awareness, Treatment and Control of Hypertension in Island of China during the 2000s: A Systematic Review_Chinese Journal of Evidence-Based Medicine

Authors：

 CHENXin ^1,2 , ZHOUBo ^1,2 , YANGBo-Wen ^1,2 , WUXiao-Mei ^1,2 , ZOUSa-Feng ³ ,  SHIJing-Pu ^1,2

1. Department of Clinical Epidemiology and Evidence-Based Medicine, the First Alienated Hospital, China Medical University, Shenyang 110001, China;
2. Evidence-Based Medicine Center of Liaoning Province, Shenyang 110001, China;
3. Dalian Central Hospital Affiliated to Dalian Medical University, Dalian 116001, China;

Corresponding author：

SHIJing-Pu, Email: sjp56@yahoo.com

Keywords：

Hypertension; Prevalence; Island; Systematic review; Meta-analysis; Cross-sectional study

DOI：

10.7507/1672-2531.20150050

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To explore the prevalence, awareness, treatment and control of hypertension in island of China. Methods Literatures regarding the prevalence and treatment of hypertension in island of China were retrieved in PubMed, EMbase, The Cochrane Library (Issue 12, 2013), CNKI, WanFang Data and CBM from January 2000 to December 2012. Two reviewers independently screened literature according to the inclusion and exclusion criteria, and extracted data. Then the pooled rates were conducted by Comprehensive Meta-Analysis software using inverse variance method. Results Nine studies involving 926 836 samples were included. The results of meta-analysis showed the pooled rates of prevalence, awareness, treatment and control were 32.0% (95%CI 18.8% to 48.8%), 47.4% (95%CI 29.7% to 65.8%), 38.0% (95%CI 23.1% to 55.5%) and 10.0% (95%CI 4.3% to 21.7%), respectively. Whether in 60 or 65 as the threshold value, the prevalence of hypertension in old people was higher than that in young people. Conclusion The prevalence of hypertension is about 32% and much higher in island regions of China, while the awareness, treatment and control rates are so lower in these regions. The relevant public health policy should pay more attention to improve primary health care in these regions.

Citation： CHENXin, ZHOUBo, YANGBo-Wen, WUXiao-Mei, ZOUSa-Feng, SHIJing-Pu. Prevalence, Awareness, Treatment and Control of Hypertension in Island of China during the 2000s: A Systematic Review. Chinese Journal of Evidence-Based Medicine, 2015, 15(3): 290-294. doi: 10.7507/1672-2531.20150050 Copy

1.	Ezzati M, Vander Hoorn S, Lawes CM, et al. Rethinking the "diseases of affluence" paradigm:global patterns of nutritional risks in relation to economic development. PLoS Med, 2005, 2(5):e133.
2.	Hu SS, Kong LZ, Gao RL, et al. Outline of the report on cardiovascular disease in China, 2010. Biomed Environ Sci, 2012, 25(3):251-256.
3.	Lenfant C, Chobanian AV, Jones DW, et al. Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7):resetting the hypertension sails. Hypertension, 2003, 41(6):1178-1179.
4.	Singer P, Gawellek F, Faulhaber HD, et al. WHO recommendations on the classification of hypertension. Dtsch Gesundheitsw, 1969, 24(17):772-775.
5.	Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology. JAMA, 2000, 283(15):2008-2012.
6.	Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses:the PRISMA statement. Int J Sur, 2010, 8(5):336-341.
7.	王通富, 盛志满, 黄友贺, 等. 玉环县沿海村民高血压调查. 浙江预防医学杂志, 2001, 13(8):19-20.
8.	张均和, 袁国裕, 阮连生. 舟山市高血压现况调查及危险因素分析. 中华航海医学与高气压医学杂志, 2006, 13(2):105-107.
9.	方快发, 吴平生, 包太成, 等. 大亚湾地区海岛渔民高血压流行病学特征及危险因素分析. 中国慢性病预防与控制, 2007, 15(3):271-272.
10.	张乾通, 张均和, 王建跃. 海岛居民高血压流行病学基线调查结果分析. 海峡预防医学杂志, 2006, 12(6):20-22.
11.	孙喜琢, 王雪, 潘晓芳, 等. 大连市獐子岛地区心血管疾病危险因素的流行病学调查. 中国心血管杂志, 2008, 13(4):280-283.
12.	黄志平, 王小华, 林加锋, 等. 海岛居民高血压患病情况调查分析. 心脑血管病防治, 2009, 9(5):31-33.
13.	Tseng LN, Tseng YH, Jiang YD, et al. Prevalence of hypertension and dyslipidemia and their associations with micro-and macrovascular diseases in patients with diabetes in Taiwan:An analysis of nationwide data for 2000-2009. J Formos Med Assoc, 2012, 111(11):625-636.
14.	周文岳, 李松涛, 刘灿磊, 等. 海岛地区 35 岁以上人群高血压流行病学调查. 心脑血管病防治, 2010, 10(6):455-457.
15.	蒋世振, 朱鹏立, 余鹏, 等. 海岛地区居民高血压患病现状及影响因素分析. 中国公共卫生, 2013, 29(10):1532-1534.
16.	Wu Y, Huxley R, Li L, et al. Prevalence, awareness, treatment, and control of hypertension in China data from the China National Nutrition and Health Survey 2002. Circulation, 2008, 118(25):2679-2686.
17.	Gu D, Reynolds K, Wu X, et al. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension, 2002, 40(6):920-927.
18.	于有利, 邓丽娟, 宁新好, 等. 长海县渔村居民高血压流行病学调查分析. 中国公共卫生, 1993, 9(10):477.
19.	Xi B, Liang Y, He T, et al. Secular trends in the prevalence of general and abdominal obesity among Chinese adults, 1993-2009. Obes Rev, 2012, 13(3):287-296.
20.	Cutler JA, Sorlie PD, Wolz M, et al. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension, 2008, 52(5):818-827.
21.	Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension, 2007, 49(1):69-75.
22.	Dickinson HO, Mason JM, Nicolson DJ, et al. Lifestyle interventions to reduce raised blood pressure:a systematic review of randomized controlled trials. J Hypertens, 2006, 24(2):215-233.
23.	He J, Muntner P, Chen J, et al. Factors associated with hypertension control in the general population of the United States. Arch Intern Med, 2002, 162(9):1051.

1. Ezzati M, Vander Hoorn S, Lawes CM, et al. Rethinking the "diseases of affluence" paradigm:global patterns of nutritional risks in relation to economic development. PLoS Med, 2005, 2(5):e133.
2. Hu SS, Kong LZ, Gao RL, et al. Outline of the report on cardiovascular disease in China, 2010. Biomed Environ Sci, 2012, 25(3):251-256.
3. Lenfant C, Chobanian AV, Jones DW, et al. Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7):resetting the hypertension sails. Hypertension, 2003, 41(6):1178-1179.
4. Singer P, Gawellek F, Faulhaber HD, et al. WHO recommendations on the classification of hypertension. Dtsch Gesundheitsw, 1969, 24(17):772-775.
5. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology. JAMA, 2000, 283(15):2008-2012.
6. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses:the PRISMA statement. Int J Sur, 2010, 8(5):336-341.
7. 王通富, 盛志满, 黄友贺, 等. 玉环县沿海村民高血压调查. 浙江预防医学杂志, 2001, 13(8):19-20.
8. 张均和, 袁国裕, 阮连生. 舟山市高血压现况调查及危险因素分析. 中华航海医学与高气压医学杂志, 2006, 13(2):105-107.
9. 方快发, 吴平生, 包太成, 等. 大亚湾地区海岛渔民高血压流行病学特征及危险因素分析. 中国慢性病预防与控制, 2007, 15(3):271-272.
10. 张乾通, 张均和, 王建跃. 海岛居民高血压流行病学基线调查结果分析. 海峡预防医学杂志, 2006, 12(6):20-22.
11. 孙喜琢, 王雪, 潘晓芳, 等. 大连市獐子岛地区心血管疾病危险因素的流行病学调查. 中国心血管杂志, 2008, 13(4):280-283.
12. 黄志平, 王小华, 林加锋, 等. 海岛居民高血压患病情况调查分析. 心脑血管病防治, 2009, 9(5):31-33.
13. Tseng LN, Tseng YH, Jiang YD, et al. Prevalence of hypertension and dyslipidemia and their associations with micro-and macrovascular diseases in patients with diabetes in Taiwan:An analysis of nationwide data for 2000-2009. J Formos Med Assoc, 2012, 111(11):625-636.
14. 周文岳, 李松涛, 刘灿磊, 等. 海岛地区 35 岁以上人群高血压流行病学调查. 心脑血管病防治, 2010, 10(6):455-457.
15. 蒋世振, 朱鹏立, 余鹏, 等. 海岛地区居民高血压患病现状及影响因素分析. 中国公共卫生, 2013, 29(10):1532-1534.
16. Wu Y, Huxley R, Li L, et al. Prevalence, awareness, treatment, and control of hypertension in China data from the China National Nutrition and Health Survey 2002. Circulation, 2008, 118(25):2679-2686.
17. Gu D, Reynolds K, Wu X, et al. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension, 2002, 40(6):920-927.
18. 于有利, 邓丽娟, 宁新好, 等. 长海县渔村居民高血压流行病学调查分析. 中国公共卫生, 1993, 9(10):477.
19. Xi B, Liang Y, He T, et al. Secular trends in the prevalence of general and abdominal obesity among Chinese adults, 1993-2009. Obes Rev, 2012, 13(3):287-296.
20. Cutler JA, Sorlie PD, Wolz M, et al. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension, 2008, 52(5):818-827.
21. Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension, 2007, 49(1):69-75.
22. Dickinson HO, Mason JM, Nicolson DJ, et al. Lifestyle interventions to reduce raised blood pressure:a systematic review of randomized controlled trials. J Hypertens, 2006, 24(2):215-233.
23. He J, Muntner P, Chen J, et al. Factors associated with hypertension control in the general population of the United States. Arch Intern Med, 2002, 162(9):1051.

Chinese Journal of Evidence-Based Medicine

Prevalence, Awareness, Treatment and Control of Hypertension in Island of China during the 2000s: A Systematic Review

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content